Company Overview
| Stock Name | 華潤醫藥集團有限公司 |
|---|---|
| Stock Code | 03320 |
| Company Full Name | 華潤醫藥集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事研發、制造、分銷及零售醫藥與其他營養保健品。 |
| Listing Date | 2016-10-28 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港灣仔港灣道26號華潤大廈41樓4104-05室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.crpharm.com |
| Share Registrar | |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 9.10 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 12.7% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 702,137,800 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 9.01 |
|---|---|
| First Day Open | HK$ 9.1 |
| First Day Change | -0.99% |
| First Day Volume | 119767000.0 |
| First Day Turnover | 1081380000.0 |
Use of Proceeds
| Use of Proceeds | 1、約45%的所得款項凈額或約港幣6,288.4百萬元預期用作戰略收購，擴大制藥及醫藥分銷業務； 2、約15%的所得款項凈額或約港幣2,096.1百萬元預期用作在中國建立更多的醫藥分銷業務的先進物流中心及倉庫； 3、約10%的所得款項凈額或約港幣1,397.4百萬元預期用作投資于研發平臺； 4、約10%的所得款項凈額或約港幣1,397.4百萬元預期用作改進及升級我們的信息技術系統； 5、約10%的所得款項凈額或約港幣1,397.4百萬元預期用作償還由華潤醫藥控股發行的部分未償還債券； 6、約10%的所得款項凈額或約港幣1,397.4百萬元預期用作營運資金及一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (4)
建银国际金融有限公司 CE AJO225
中国国际金融香港证券有限公司 CE AEN894
高盛（亚洲）有限责任公司 CE ACC536
Merrill Lynch (Asia Pacific) Limited CE AAC198
Overall Coordinators (5)
中国国际金融香港证券有限公司 CE AEN894
高盛（亚洲）有限责任公司 CE ACC536
Merrill Lynch (Asia Pacific) Limited CE AAC198
建银国际金融有限公司 CE AJO225
摩根士丹利亚洲有限公司 CE AAD291
Joint Bookrunners (14)
中国国际金融香港证券有限公司 CE AEN894
高盛（亚洲）有限责任公司 CE ACC536
Merrill Lynch (Asia Pacific) Limited CE AAC198
建银国际金融有限公司 CE AJO225
摩根士丹利亚洲有限公司 CE AAD291
招商证券（香港）有限公司 CE AAI650
工银国际融资有限公司 CE AQW615
香港上海汇丰银行有限公司
瑞穗证券亚洲有限公司 CE AEZ953
中信建投（国际）融资有限公司 CE BAU112
中银国际亚洲有限公司 CE AET863
招银国际融资有限公司 CE AVM940
农银国际融资有限公司 CE AWL249
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
Joint Lead Managers (14)
中国国际金融香港证券有限公司 CE AEN894
高盛（亚洲）有限责任公司 CE ACC536
Merrill Lynch (Asia Pacific) Limited CE AAC198
建银国际金融有限公司 CE AJO225
摩根士丹利亚洲有限公司 CE AAD291
招商证券（香港）有限公司 CE AAI650
工银国际证券有限公司 CE ARO299
香港上海汇丰银行有限公司
瑞穗证券亚洲有限公司 CE AEZ953
中信建投（国际）融资有限公司 CE BAU112
中银国际亚洲有限公司 CE AET863
招银国际融资有限公司 CE AVM940
农银国际证券有限公司 CE ACX411
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | High Action Limited | 233,997,400 HKD | — | 0.42% | — | 6 months | 2017-04-28 |
| 2 | London International Trading (Asia) Limited | 387,905,700 HKD | — | 0.69% | — | 6 months | 2017-04-28 |
| 3 | Nordea Investment Management AB | 699,999,300 HKD | — | 1.25% | — | 6 months | 2017-04-28 |
| 4 | 安邦投资控股有限公司 | 379,433,600 HKD | — | 0.68% | — | 6 months | 2017-04-28 |
| 5 | 富士胶片公司 | 819,996,450 HKD | — | 1.46% | — | 6 months | 2017-04-28 |
| 6 | 恒健国际投资控股(香港)有限公司 | 2,637,953,500 HKD | — | 4.70% | — | 6 months | 2017-04-28 |
| 7 | 中国诚通控股集团有限公司 | 387,933,000 HKD | — | 0.69% | — | 6 months | 2017-04-28 |
| 8 | 中国人寿保险(集团)公司 | 1,551,732,000 HKD | — | 2.76% | — | 6 months | 2017-04-28 |
Directors & Management
| Chairman | 白曉松 |
|---|---|
| Company Secretary | 溫詠宜 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 華潤(集團)有限公司(53.05%);Beijing State Assets Management and Administration Center(20.63%) |
|---|
